Document is current
Any future updates will be listed below
-
Authors
Cahalane, Rachel M. E.
Cruts, Janneke M. H.
van Beusekom, Heleen M. M.
de Maat, Moniek P. M.
Dijkshoorn, Marcel
van der Lugt, Aad
Gijsen, Frank J. H. https://orcid.org/0000-0001-5246-9060
-
Funding
Funding for this research was provided by:
Technische Universiteit Delft (Impulse program)
HORIZON EUROPE Framework Programme (777072)
- License Information
-
More Information
Article History
Received: 29 October 2023
Accepted: 6 April 2024
First Online: 25 April 2024
Declarations
:
: Dr van Beusekom reports grants from the Dutch Heart Foundation and consulting fees from Thuja Healthcare investments. Dr de Maat reports grants from the Dutch Thrombosis Foundation. Mr Dijkshoorn reports consulting fees and payments from Siemens Healthineers and Kalcio Healthcare. Dr van der Lugt reports funding for research from Stryker, Penumbra, Medtronic, Cerenovus, Thrombolytic Science LLC, Dutch Heart Foundation, Brain Foundation Netherlands, The Netherlands Organization for Health Research and Development, Health Holland Top Sector Life Sciences and Health, The Netherlands Organization for Health Research and Development and Boehringer all paid to institution and consulting fee from Bracco, also paid to the institution. The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
